Publications by authors named "Nour Ass'ad"
Article Synopsis
- The Southwestern United States has a history of mining, particularly uranium, which exposes miners to dust-related health risks, including autoimmune diseases, but little research has been done on autoimmune biomarkers in this population.
- A pilot study recruited 44 miners to assess autoantibodies linked to their exposure, employing a mobile clinical platform for easier access to healthcare in remote areas.
- Results showed a significant link between U-mining exposure and specific autoantibodies, highlighting the need for further research into the mechanisms behind these immune responses, particularly related to histones.
The United States has a rich history of mining including uranium (U)-mining, coal mining, and other metal mining. Cardiovascular diseases (CVD) are largely understudied in miners and recent literature suggests that when compared to non-U miners, U-miners are more likely to report CVD. However, the molecular basis for this phenomenon is currently unknown.
View Article and Find Full Text PDFBosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment.
View Article and Find Full Text PDFObjective: The aim of this study was to test the hypothesis that uranium miners in New Mexico (NM) have a greater prevalence of cardiovascular disease than miners who extracted the nonuranium ore.
Methods: NM-based current and former uranium miners were compared with nonuranium miners by using cross-sectional standardized questionnaire data from the Mining Dust in the United States (MiDUS) study from 1989 to 2016.
Results: Of the 7215 eligible miners, most were men (96.